newsfilter
← Latest News
GlobeNewswire·

Regen BioPharma, Inc. Expands Vision for Phase 1 Clinical Trial of HemaXellerate™

Targeting Transformative Solutions for Aplastic Anemia and Beyond SAN DIEGO, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Regen BioPharma, Inc. (OTC:RGBP) today provided further insight into its planned Phase 1 clinical trial